|
1
|
Feigin VL, Norrving B, George MG, Foltz
JL, Roth GA and Mensah GA: Prevention of stroke: A strategic global
imperative. Nat Rev Neurol. 12:501–512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li JL, Wu L, Wu J, Feng HX, Wang HM, Fu Y,
Zhang RJ, Zhang HY and Zhao WM: Caffeoyl triterpenoid esters as
potential anti-ischemic stroke agents from Celastrus orbiculatus. J
Nat Prod. 79:2774–2779. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fisher M and Saver JL: Future directions
of acute ischaemic stroke therapy. Lancet Neurol. 14:758–767. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Doyle KP, Simon RP and Stenzel-Poore MP:
Mechanisms of ischemic brain damage. Neuropharmacology. 55:310–318.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mehta SL, Manhas N and Raghubir R:
Molecular targets in cerebral ischemia for developing novel
therapeutics. Brain Res Rev. 54:34–66. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thompson JW, Narayanan SV and Perez-Pinzon
MA: Redox signaling pathways involved in neuronal ischemic
preconditioning. Curr Neuropharmacol. 10:354–369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Zhu X, Chen M, Ge Q, Shen Y and Pan
S: Resveratrol protects PC12 cells against OGD/R-induced apoptosis
via the mitochondrial-mediated signaling pathway. Acta Biochim
Biophys Sin (Shanghai). 48:342–353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Z, Weian C, Susu H and Hanmin W:
Protective effects of mangiferin on cerebral ischemia-reperfusion
injury and its mechanisms. Eur J Pharmacol. 771:145–151. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Xu H, Xin Y, Li M, Fu W, Wang Y,
Lu Z, Yu X and Sui D: Neuroprotective effects of
kaempferide-7-O-(4′-O-acetylrhamnosyl)-3-O-rutinoside on cerebral
ischemia-reperfusion injury in rats. Eur J Pharmacol. 788:335–342.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho WS, Xue JY, Sun SS, Ooi VE and Li YL:
Antiviral activity of daphnoretin isolated from Wikstroemia indica.
Phytother Res. 24:657–661. 2010.PubMed/NCBI
|
|
11
|
Nunome S, Ishiyama A, Kobayashi M, Otogulo
K, Kiyohara H, Yamada H and Omura S: In vitro antimalarial activity
of biflavonoids from Wikstroemia indica. Planta Med. 70:76–78.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu K, Kobayashi H, Dong A, Iwasaki S and
Yao X: Antifungal, antimitotic and anti-HIV-1 agents from the roots
of Wikstroemia indica. Planta Med. 66:564–567. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Wang G, Huang W, Ye W and Li Y:
Biflavonoids from the roots of Wikstroemia indica. Nat Prod Commun.
6:1111–1114. 2011.PubMed/NCBI
|
|
14
|
Wang GC, Zhang XL, Wang YF, Li GQ, Ye WC
and Li YL: Four new dilignans from the roots of Wikstroemia indica.
Chem Pharm Bull (Tokyo). 60:920–923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang LY, Unehara N and Kitanaka S: Lignans
from the roots of Wikstroemia indica and their DPPH radical
scavenging and nitric oxide inhibitory activities. Chem Pharm Bull
(Tokyo). 53:1348–1351. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Fu WW, Sun LX, Wang Q, Qi W and Yu
H: A new coumarin from Wikstroemia indica (L.) C. A. Mey. Chin Chem
Lett. 20:592–594. 2009. View Article : Google Scholar
|
|
17
|
Lu CL, Li YM, Fu GQ, Yang LI, Jiang JG,
Zhu L, Lin FL, Chen J and Lin QS: Extraction optimisation of
daphnoretin from root bark of Wikstroemia indica (L.) C.A. and its
anti-tumour activity tests. Food Chem. 124:1500–1506. 2011.
View Article : Google Scholar
|
|
18
|
Me H, Zhong Y and Yin J: Chemical
constituents from Wikstroemia indica. Chin Trad Herbal Drugs.
38:669–670. 2007.(In Chinese).
|
|
19
|
Cai M, Ma Y, Zhang W, Wang S, Wang Y, Tian
L, Peng Z, Wang H and Qingrong T:
Apigenin-7-O-β-D-(−6′-p-coumaroyl)-glucopyranoside treatment
elicits neuroprotective effect against experimental ischemic
stroke. Int J Biol Sci. 12:42–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Agrawal M, Kumar V, Singh AK, Kashyap MP,
Khanna VK, Siddiqui MA and Pant AB: Trans-resveratrol protects
ischemic PC12 cells by inhibiting the hypoxia associated
transcription factors and increasing the levels of antioxidant
defense enzymes. ACS Chem Neurosci. 4:285–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li YY, Xiao L, Qiu LY, Yan YF, Wang H,
Duan GL, Liao ZP and Chen HP: Sasanquasaponin-induced
cardioprotection involves inhibition of mPTP opening via
attenuating intracellular chloride accumulation. Fitoterapia.
116:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu JR, Tao YF, Lou S and Wu ZM:
Protective effects of ginsenoside Rb(3) on oxygen and glucose
deprivation-induced ischemic injury in PC12 cells. Acta Pharmacol
Sin. 31:273–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Görlach A, Bertram K, Hudecova S and
Krizanova O: Calcium and ROS: A mutual interplay. Redox Biol.
6:260–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fiskum G, Rosenthal RE, Vereczki V, Martin
E, Hoffman GE, Chinopoulos C and Kowaltowski A: Protection against
ischemic brain injury by inhibition of mitochondrial oxidative
stress. J Bioenerg Biomembr. 36:347–352. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niizuma K, Endo H and Chan PH: Oxidative
stress and mitochondrial dysfunction as determinants of ischemic
neuronal death and survival. J Neurochem 109 Suppl. 1:133–138.
2009. View Article : Google Scholar
|
|
26
|
Hurst S, Hoek J and Sheu SS: Mitochondrial
Ca2+ and regulation of the permeability transition pore. J Bioenerg
Biomembr. 49:27–47. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan PH: Reactive oxygen radicals in
signaling and damage in the ischemic brain. J Cereb Blood Flow
Metab. 21:2–14. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
